Went bankrupt in Apr 2023
IVC - Invacare Corporation
NYSE
->
Healthcare
->
Medical Devices
Elyria,
United States
Type: Equity
IVC price evolution
IVC
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $45.44 | $43.91 | $52.34 | $83.75 |
| Short term investments | ||||
| Net receivables | $80.36 | $91.23 | $106.66 | $117.33 |
| Inventory | $120.69 | $138.81 | $147.35 | $144.27 |
| Total current assets | $294.82 | $317.05 | $350.48 | $385.39 |
| Long term investments | ||||
| Property, plant & equipment | $119.31 | $126.08 | $132.59 | $136.55 |
| Goodwill & intangible assets | $338.14 | $362.83 | $378.57 | $382.23 |
| Total noncurrent assets | $462.78 | $495.58 | $516.79 | $524.14 |
| Total investments | ||||
| Total assets | $757.61 | $812.62 | $867.27 | $909.53 |
| Current liabilities | ||||
| Accounts payable | $95.97 | $111.56 | $121.11 | $130.04 |
| Deferred revenue | ||||
| Short long term debt | $8.24 | $8.8 | $9.98 | $10.33 |
| Total current liabilities | $222.68 | $227.61 | $233.2 | $247.25 |
| Long term debt | $397.5 | $379.26 | $379.51 | $376.99 |
| Total noncurrent liabilities | $453.88 | $437.4 | $444.76 | $443.79 |
| Total debt | $405.75 | $388.05 | $389.49 | $387.32 |
| Total liabilities | $676.56 | $665.02 | $677.96 | $691.04 |
| Shareholders' equity | ||||
| Retained earnings | -$57.85 | -$23.5 | -$1.55 | $22.64 |
| Other shareholder equity | -$45.11 | -$9.88 | $11.69 | $16.99 |
| Total shareholder equity | $81.05 | $147.6 | $189.31 | $218.49 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $83.75 | $105.3 | $80.06 | $116.91 |
| Short term investments | ||||
| Net receivables | $117.33 | $108.97 | $117.41 | $121.32 |
| Inventory | $144.27 | $115.48 | $120.5 | $128.12 |
| Total current assets | $385.39 | $374.47 | $355.88 | $397.41 |
| Long term investments | ||||
| Property, plant & equipment | $136.55 | $135.37 | $92.18 | $74.31 |
| Goodwill & intangible assets | $382.23 | $430.22 | $399.85 | $407.78 |
| Total noncurrent assets | $524.14 | $571.51 | $496.25 | $488.44 |
| Total investments | ||||
| Total assets | $909.53 | $945.98 | $852.13 | $885.86 |
| Current liabilities | ||||
| Accounts payable | $130.04 | $85.42 | $88 | $92.47 |
| Deferred revenue | ||||
| Short long term debt | $10.33 | $15.33 | $9.36 | $2.11 |
| Total current liabilities | $247.25 | $230.39 | $218.66 | $198.21 |
| Long term debt | $376.99 | $311.27 | $258 | $253.53 |
| Total noncurrent liabilities | $443.79 | $381.75 | $324.95 | $328.5 |
| Total debt | $387.32 | $326.61 | $267.37 | $255.65 |
| Total liabilities | $691.04 | $612.13 | $543.61 | $526.71 |
| Shareholders' equity | ||||
| Retained earnings | $22.64 | $58.54 | $87.47 | $142.45 |
| Other shareholder equity | $16.99 | $45.44 | $3.13 | $12.79 |
| Total shareholder equity | $218.49 | $333.85 | $308.52 | $359.15 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $170.41 | $189.02 | $200.99 | $226.19 |
| Cost of revenue | $139.03 | $141.11 | $153.34 | $162.78 |
| Gross Profit | $31.38 | $47.91 | $47.65 | $63.41 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $55.37 | $58.65 | $60.59 | $53.49 |
| Total operating expenses | $64.82 | $62.81 | $64.38 | $53.55 |
| Operating income | -$33.44 | -$14.9 | -$16.73 | $9.86 |
| Income from continuing operations | ||||
| EBIT | -$26.08 | -$21.02 | -$22.87 | $27.86 |
| Income tax expense | $0.92 | $0.92 | $1.32 | $1.61 |
| Interest expense | $7.35 | $0 | $0 | $24.3 |
| Net income | ||||
| Net income | -$34.35 | -$21.94 | -$24.2 | $1.94 |
| Income (for common shares) | -$34.35 | -$21.94 | -$24.2 | $1.94 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $872.46 | $850.69 | $927.96 | $972.35 |
| Cost of revenue | $633.35 | $605.44 | $665.9 | $704.67 |
| Gross Profit | $239.11 | $245.25 | $262.07 | $267.68 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $232.24 | $236.36 | $260.06 | $281.91 |
| Total operating expenses | $263.34 | $243.72 | $272.48 | $285.97 |
| Operating income | -$24.23 | $1.54 | -$10.41 | -$18.29 |
| Income from continuing operations | ||||
| EBIT | -$14.81 | $4.06 | -$14.95 | -$5.77 |
| Income tax expense | $6.45 | $3.84 | $9.3 | $9.82 |
| Interest expense | $24.31 | $28.5 | $29.08 | $28.34 |
| Net income | ||||
| Net income | -$45.56 | -$28.28 | -$53.33 | -$43.92 |
| Income (for common shares) | -$45.56 | -$28.28 | -$53.33 | -$43.92 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$34.35 | -$21.94 | -$24.2 | $1.94 |
| Operating activities | ||||
| Depreciation | $5.13 | $5.1 | $5.32 | $5.83 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | -$0.44 | $1.97 | $0.31 | -$1.05 |
| Total cash flows from operations | -$19.93 | $0.76 | -$27.7 | $22.52 |
| Investing activities | ||||
| Capital expenditures | -$0.54 | -$0.63 | -$2.13 | -$3.29 |
| Investments | ||||
| Total cash flows from investing | -$1.13 | -$0.57 | -$2.21 | -$3.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.15 | -$0 | ||
| Net borrowings | $25.1 | -$6.43 | -$1.18 | -$6.91 |
| Total cash flows from financing | $25.1 | -$6.58 | -$1.18 | -$6.91 |
| Effect of exchange rate | -$2.52 | -$2.03 | -$0.32 | -$2.18 |
| Change in cash and equivalents | $1.53 | -$8.43 | -$31.41 | $10.09 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$45.56 | -$28.28 | -$53.33 | -$43.92 |
| Operating activities | ||||
| Depreciation | $23.09 | $21.27 | $24.49 | $15.56 |
| Business acquisitions & disposals | $14.56 | |||
| Stock-based compensation | $4.32 | $8.64 | $11.11 | $5.28 |
| Total cash flows from operations | -$14.31 | $21.92 | $2.74 | -$46.42 |
| Investing activities | ||||
| Capital expenditures | -$17.66 | -$21.91 | -$10.8 | -$6.26 |
| Investments | ||||
| Total cash flows from investing | -$17.8 | -$9.55 | -$11.61 | -$6.36 |
| Financing activities | ||||
| Dividends paid | -$0.41 | -$1.65 | -$1.63 | |
| Sale and purchase of stock | -$1.75 | -$1.71 | -$0.89 | $0.2 |
| Net borrowings | $33.41 | $8.38 | -$25.4 | -$1.49 |
| Total cash flows from financing | $12.87 | $6.26 | -$27.94 | -$2.92 |
| Effect of exchange rate | -$2.31 | $6.61 | -$0.03 | -$3.91 |
| Change in cash and equivalents | -$21.55 | $25.23 | -$36.84 | -$59.62 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 37.80M |
| Revenue | $786.60M |
|---|---|
| EBITDA | -$20.75M |
| EBIT | -$42.12M |
| Net Income | -$78.56M |
| Revenue Q/Q | -23.99% |
| Revenue Y/Y | -9.62% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 3.34 |
| Cash/Share | 1.20 |
| EPS | -$2.08 |
|---|---|
| ROA | -9.39% |
| ROE | -49.37% |
| Debt/Equity | 3.16 |
|---|---|
| Net debt/EBITDA | -30.42 |
| Current ratio | 1.32 |
| Quick ratio | 0.78 |